As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/14/24  Allogene Therapeutics, Inc.       S-8         3/14/24    4:83K                                    Donnelley … Solutions/FA 
 3/14/24  Allogene Therapeutics, Inc.       S-3                    8:1.1M                                   Donnelley … Solutions/FA 
 3/14/24  Allogene Therapeutics, Inc.       POSASR      3/14/24    4:555K                                   Donnelley … Solutions/FA 
 11/2/23  Allogene Therapeutics, Inc.       10-Q        9/30/23   65:7.6M                                                            
 2/28/23  Allogene Therapeutics, Inc.       S-8         2/28/23    4:130K                                                            
 11/2/22  Allogene Therapeutics, Inc.       S-3ASR      11/2/22    9:1.7M                                                            
 2/23/22  Allogene Therapeutics, Inc.       S-8         2/23/22    4:119K                                                            
 2/25/21  Allogene Therapeutics, Inc.       S-8         2/25/21    3:109K                                                            

____________
¹	Filing/Form Types:
	10-Q	Quarterly Report — Form 10-Q.
	POSASR	Post-Effective Amendment of an Automatic Shelf Registration Statement — Form S-3/F-3ASR.
	S-3	Registration Statement – Securities for a Transaction — Form S-3.
	S-3ASR	Automatic Shelf Registration Statement by a Well-Known Issuer — Form S-3.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.